These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18644230)

  • 1. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.
    Occleston NL; Laverty HG; O'Kane S; Ferguson MW
    J Biomater Sci Polym Ed; 2008; 19(8):1047-63. PubMed ID: 18644230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β3 for the prevention of vocal fold scarring.
    Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Ishikawa S; Mizuta M; Tateya I; Nakamura T; Ito J
    Laryngoscope; 2012 Mar; 122(3):583-9. PubMed ID: 22252900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of buccal mucosa scarring with transforming growth factor β3.
    Ohno S; Hirano S; Kanemaru S; Tateya I; Kitani Y; Kojima T; Nakamura T; Ito J
    Laryngoscope; 2011 Jul; 121(7):1404-9. PubMed ID: 21647892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds.
    Vooijs DP; Walboomers XF; Parker JA; Von den Hoff JW; Jansen JA
    J Biomed Mater Res A; 2004 Sep; 70(3):402-11. PubMed ID: 15293313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.
    Occleston NL; Fairlamb D; Hutchison J; O'Kane S; Ferguson MW
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1231-9. PubMed ID: 19604123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.
    Occleston NL; O'Kane S; Laverty HG; Cooper M; Fairlamb D; Mason T; Bush JA; Ferguson MW
    Wound Repair Regen; 2011 Sep; 19 Suppl 1():s38-48. PubMed ID: 21793965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avotermin: a novel antiscarring agent.
    Durani P; Occleston N; O'Kane S; Ferguson MW
    Int J Low Extrem Wounds; 2008 Sep; 7(3):160-8. PubMed ID: 18757391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapies for scar reduction and regenerative healing of skin wounds.
    Rhett JM; Ghatnekar GS; Palatinus JA; O'Quinn M; Yost MJ; Gourdie RG
    Trends Biotechnol; 2008 Apr; 26(4):173-80. PubMed ID: 18295916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutics for the prevention and reduction of scarring.
    Occleston NL; O'Kane S; Goldspink N; Ferguson MW
    Drug Discov Today; 2008 Nov; 13(21-22):973-81. PubMed ID: 18824245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
    Ferguson MW; Duncan J; Bond J; Bush J; Durani P; So K; Taylor L; Chantrey J; Mason T; James G; Laverty H; Occleston NL; Sattar A; Ludlow A; O'Kane S
    Lancet; 2009 Apr; 373(9671):1264-74. PubMed ID: 19362676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds.
    Ono I; Yamashita T; Hida T; Jin HY; Ito Y; Hamada H; Akasaka Y; Ishii T; Jimbow K
    J Surg Res; 2004 Jul; 120(1):47-55. PubMed ID: 15172189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
    Shah M; Foreman DM; Ferguson MW
    J Cell Sci; 1995 Mar; 108 ( Pt 3)():985-1002. PubMed ID: 7542672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for adult dermal wound healing.
    Birch M; Tomlinson A; Ferguson MW
    Methods Mol Med; 2005; 117():223-35. PubMed ID: 16118455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coacervate-mediated exogenous growth factor delivery for scarless skin regeneration.
    Park U; Lee MS; Jeon J; Lee S; Hwang MP; Wang Y; Yang HS; Kim K
    Acta Biomater; 2019 May; 90():179-191. PubMed ID: 30936036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep dermal burn injury results in scarless wound healing in the ovine fetus.
    Fraser JF; Cuttle L; Kempf M; Phillips GE; O'Rourke PK; Choo K; Hayes MT; Kimble RM
    Wound Repair Regen; 2005; 13(2):189-97. PubMed ID: 15828944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The morphologic characteristics of scar tissues and the new clinicomorphologic classification of human skin scars].
    Shekhter AB; Guller AE
    Arkh Patol; 2008; 70(1):6-13. PubMed ID: 18368800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyhydroxybutyrate-co-hydroxyvalerate structures loaded with adipose stem cells promote skin healing with reduced scarring.
    Zonari A; Martins TM; Paula AC; Boeloni JN; Novikoff S; Marques AP; Correlo VM; Reis RL; Goes AM
    Acta Biomater; 2015 Apr; 17():170-81. PubMed ID: 25662911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regeneration of Dermis: Scarring and Cells Involved.
    Rippa AL; Kalabusheva EP; Vorotelyak EA
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reinnervation pattern of wounds and scars after treatment with transforming growth factor β isoforms.
    Henderson J; Ferguson MW; Terenghi G
    J Plast Reconstr Aesthet Surg; 2012 Apr; 65(4):e80-6. PubMed ID: 22240245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.